Skip to main content

and
  1. No Access

    Chapter

    Strategies to Optimize Peptide Stability and Prolong Half-Life

    Peptide drugs represent 5% of the global pharmaceutical market, but growing twice as fast as the rest of the drug market. The development of peptide therapeutics is challenging due to their low stability, shor...

    Sophia M. Shi, Li Di in Peptide Therapeutics (2022)

  2. No Access

    Chapter

    Overview of the Impact of Protein Interfacial Instability on the Development of Biologic Products

    Interfacial phenomena can significantly affect the development, manufacturing, stability, and use of therapeutic proteins. Proteins are exposed to air-liquid, solid-liquid, and liquid-liquid interfaces through...

    **jiang Li, Mary E. Krause, Raymond Tu in Protein Instability at Interfaces During D… (2021)

  3. No Access

    Chapter

    Future Perspectives

    In this chapter, we describe future perspectives of product development of biologics with an emphasis on the effect of interfacial stress on product performance and development, including analytical detection,...

    **jiang Li in Protein Instability at Interfaces During Drug Product Development (2021)

  4. No Access

    Chapter

    Physical Stabilization of Proteins in Aqueous Solution

    The formulation scientist’s key goal is to achieve long-term stability of a drug compound. In the case of protein drugs, stabilization means not only maintaining the native chemical structure, but the native s...

    Brent S. Kendrick, Tiansheng Li in Rational Design of Stable Protein Formulat… (2002)

  5. No Access

    Chapter

    Recombinant Production of Native Proteins from Escherichia coli

    The production of large quantities of proteins became possible with the advent of recombinant DNA technology, and the subsequent expression of recombinant proteins in Escherichia coli (E. coli) (Itakura, 1977). R...

    Tsutomu Arakawa, Tiansheng Li in Rational Design of Stable Protein Formulat… (2002)

  6. No Access

    Chapter

    Liposome-Mediated Delivery of Genes and Oligonucleotides for the Treatment of Brain Tumors

    Brain tumors present a great therapeutic challenge due to their very poor prognosis (Mahaley et al, 1989). On the other hand, brain tumors have some features that make them particularly attractive for in vivo ...

    Jianhong Zhu, Li Zhang, Regina Reszka in Targeting of Drugs 5 (1996)